Sources of gaseous contamination in Pharma
By-products from manufacturing processes, olatile substances or impurities in raw materials, Evaporation of organic solvents, leading to VOC emissions, Gases emitted during packaging and sealing
Problems with gaseous contaminants in Pharmaceutical Industry
-
Impact on Drug Quality
Volatile organic compounds (VOCs), ammonia, or sulfur-based gases can interact with raw materials and active pharmaceutical ingredients (APIs), leading to contamination or chemical degradation. -
Cross-Contamination
Airborne contaminants can spread between production lines or batches, affecting product purity. -
Corrosion of Machinery
Corrosive gases like hydrogen sulfide (H₂S) and sulfur dioxide (SO₂) can damage sensitive manufacturing equipment, reducing operational efficiency and increasing maintenance costs. -
Clogging and Fouling
Gaseous contaminants can clog air intake systems, filters, and ducts, hindering production processes. -
Worker helath risks
Respiratory issues and exposure to hazardous chemicals - Process inefficiency
- Odour and Environmental concerns
Problems with gaseous contaminants in Pharmaceutical Industry
- Reduced efficacy of the product, Regulatory and compliance issues, Product recalls, Increased operational costs, Health related absenteeism, impact on workers productivity, Reputation Damage, Environmental impact
How can we Help?
- Our made to suit activated carbon based products can help mitigate the indoor recirculation problems and exhaust solution to protect the environment. We treat more than 8000 gases with our unique and customized solutions.
